Introduction: the evolving role of bisphosphonate therapy in multiple myeloma

Blood. 2000 Jul 15;96(2):381-3.

Authors

N Raje¹, K C Anderson

Affiliation

¹ Dana-Farber Cancer Institute, Boston, MA 02115, USA.

PMID: 10887095

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / therapeutic use
Bone Resorption / etiology
Bone Resorption / prevention & control
Diphosphonates / therapeutic use*
Humans
Interleukin-6 / antagonists & inhibitors
Interleukin-6 / biosynthesis
Multiple Myeloma / complications
Multiple Myeloma / drug therapy*
Osteoclasts / physiology

Substances

Antineoplastic Agents
Diphosphonates
Interleukin-6